Pharmac funds second SMA therapy

By Megan Brodie 3 years ago | In New Zealand, Reimbursement
  • 3 years ago

12 April 2023 New Zealand’s Pharmac has swiftly followed the funding of Biogen’s first-in-class therapy…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads